MOH — authorised 22 June 1982
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: likely_approved
🇮🇱 Renacidin in Israel
MOH authorised Renacidin on 22 June 1982
Marketing authorisation
Renacidin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Israel
Frequently asked questions
Is Renacidin approved in Israel?
Yes. MOH authorised it on 22 June 1982.
Who is the marketing authorisation holder for Renacidin in Israel?
BAXTER HLTHCARE holds the Israeli marketing authorisation.